Over the past decade, reported morbidity and mortality rates from community acquired pneumonia (CAP) have stagnated.

Corey Diamond, PharmD

Empirical antimicrobial therapy for BSIs may decrease in-hospital mortality.

Released in late 2022, CDC’s most recent National and State Healthcare-Associated Infections (HAI) Progress Report examined the prevalence of 6 common infections across 3 health care settings: acute care hospitals (ACHs), inpatient rehabilitation facilities, and long-term acute care hospitals.

Olivia C. Welter, PharmD

A study published in Pharmacotherapy on November 19, 2022, challenges the long-held notion that renal function should be adjusted based on race.

Corey Diamond, PharmD

On October 26, 2017, the opioid crisis was officially declared a public health emergency in the United States. Since then, opioid overdoses have failed to decline—CDC’s 2020 data on opioid overdoses demonstrated a 31% increase over 2019.

Ariel Clark, PharmD

A new study published in JAMA investigated how various treatment interventions affected long-term outcomes in critically ill patients with COVID-19.

Olivia C. Welter, PharmD

Hydroxychloroquine and the risk for incident retinopathy.

On January 4, 2023, APhA hosted an open forum as part of the Pulse on Practice and Policy Open Forum Series to discuss the drug shortages that pharmacies are facing nationwide

Morgan Carson-Marino, PharmD, MS

Cardiovascular disease (CVD) is a significant global health issue.

Corey Diamond, PharmD

Over the course of the pandemic, researchers raced to find effective treatments for patients with COVID-19.

Lauren Howell, PharmD